Fukushima, Japan

Jun Sasamori

This inventor holds 1 USPTO granted patent. Top assignee: Toa Eiyo Ltd.. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jun Sasamori. Retrieved from https://idiyas.com/inventor/jun-sasamori

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Jun Sasamori

Introduction: Jun Sasamori is a notable inventor based in Fukushima, Japan. He has made significant contributions to the field of chemistry, particularly in the development of novel compounds. His work has led to the creation of a unique patent that showcases his innovative approach to drug development.

Latest Patents: Jun Sasamori holds a patent for "Cycloalka[b]pyridine-3-carbonylguanidine derivatives, process for producing the same, and drugs containing the same." This invention relates to a cycloalka[b]pyridine-3-carbonylguanidine derivative represented by a specific general formula. The patent highlights the potential applications of these derivatives in pharmaceutical formulations.

Career Highlights: Throughout his career, Jun Sasamori has demonstrated a commitment to advancing scientific knowledge and practical applications in his field. His innovative spirit has led to the successful development of his patented compounds, which may have significant implications for drug discovery and development.

Collaborations: Jun Sasamori has worked alongside talented colleagues, including Atsuo Takahashi and Kaoru Genkyou. Their collaborative efforts have contributed to the success of his research and the advancement of their shared goals in the field of chemistry.

Conclusion: Jun Sasamori's contributions to the field of chemistry through his innovative patent exemplify the importance of research and collaboration in driving scientific progress. His work continues to inspire future innovations in drug development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…